Research Reference Library · Educational Use Only

GLP-1 Peptide Injection Guide: Equipment, Technique & Best Practices

Last reviewed 2026 · Source: peer-reviewed preclinical literature

Equipment Required

Step-by-Step Injection Protocol

  1. Wash hands thoroughly with soap and water for 20 seconds.
  2. Remove the peptide vial from refrigeration and allow it to reach room temperature (10–15 minutes) to reduce injection discomfort.
  3. Wipe the rubber stopper of the vial with an alcohol swab. Allow to air dry for 10 seconds.
  4. Draw air into the syringe equal to the volume you will withdraw. Inject this air into the vial before drawing the peptide solution — this equalises pressure and prevents vacuum build-up.
  5. Invert the vial, insert the needle, and slowly draw the correct volume of solution.
  6. Remove any air bubbles by holding the syringe needle-up and gently tapping until bubbles rise, then expelling them.
  7. Clean the injection site with an alcohol swab. Allow to dry fully.
  8. Pinch the skin lightly, insert the needle at a 45–90 degree angle (45° for lean subjects, 90° for subcutaneous fat ≥1 cm depth), and inject slowly.
  9. Withdraw the needle and apply gentle pressure with a clean swab. Do not rub.
  10. Dispose of the needle in a sharps container immediately.

Injection Sites

For subcutaneous GLP-1 peptide research, the three primary injection sites are the abdomen (2–5 cm from the navel), the outer thigh, and the back of the upper arm. Rotate sites with each injection to prevent lipohypertrophy (fatty tissue build-up at injection sites). Avoid injecting into areas of active lipohypertrophy as absorption is inconsistent.

Managing Post-Injection Nausea

GLP-1 class peptides (Semaglutide, Tirzepatide, Retatrutide) slow gastric emptying. Administering injections in the evening and reducing meal size on injection day significantly reduces nausea. Avoid high-fat meals within 4 hours of injection. If nausea is severe, hold the current dose for an additional 4 weeks before escalating.

Storage After Drawing

Never pre-draw syringes and store for later use. Draw only the dose required immediately before administration. Reconstituted peptide in a vial is stable for 21–28 days at 2–8°C; once in a syringe and exposed to air it should be administered within minutes.

Research-grade peptides with HPLC-verified COA
All compounds referenced in this guide are available at QSC Peptides (qscpeptide.com) — US domestic warehouse, fast shipping, batch-level certificates of analysis.

This page is for educational and research purposes only. All products sold by QSC are labelled for research use only and are not intended for human consumption. Nothing on this page constitutes medical advice.